Embracing Changes Center For Wellness Llc | |
4830 W Kennedy Blvd Ste 630 Tampa FL 33609-2571 | |
(813) 486-4920 | |
(813) 428-5756 |
Full Name | Embracing Changes Center For Wellness Llc |
---|---|
Speciality | Social Worker |
Location | 4830 W Kennedy Blvd Ste 630, Tampa, Florida |
Authorized Official Name and Position | Karen Perez (PRESIDENT) |
Authorized Official Contact | 8134937705 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Embracing Changes Center For Wellness Llc 32450 Talimena Loop Wesley Chapel FL 33543-5839 Ph: (813) 486-4920 | Embracing Changes Center For Wellness Llc 4830 W Kennedy Blvd Ste 630 Tampa FL 33609-2571 Ph: (813) 486-4920 |
NPI Number | 1003477662 |
---|---|
Provider Enumeration Date | 06/25/2019 |
Last Update Date | 02/21/2022 |
Certification Date | 02/17/2021 |
Medicare PECOS PAC ID | 1951713361 |
---|---|
Medicare Enrollment ID | O20201209000218 |
News Archive
Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows. The risk was highest in the first two months of opioid use.
Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented.
A study published in Science examines a key player in conditions such as cancer, inflammatory bowel disease, rheumatoid arthritis and asthma and has shown that cells use a sophisticated communication system to coordinate responses to infection and maintain inflammation in the body.
› Verified 4 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003477662 | NPI | - | NPPES |
SW11254 | Other | FL | DOH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Provider Name | Karen Perez |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1649485822 PECOS PAC ID: 3375767494 Enrollment ID: I20140611001854 |
News Archive
Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows. The risk was highest in the first two months of opioid use.
Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented.
A study published in Science examines a key player in conditions such as cancer, inflammatory bowel disease, rheumatoid arthritis and asthma and has shown that cells use a sophisticated communication system to coordinate responses to infection and maintain inflammation in the body.
› Verified 4 days ago
Provider Name | Regina May Velasco |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1851407613 PECOS PAC ID: 7012153703 Enrollment ID: I20201209001312 |
News Archive
Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows. The risk was highest in the first two months of opioid use.
Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented.
A study published in Science examines a key player in conditions such as cancer, inflammatory bowel disease, rheumatoid arthritis and asthma and has shown that cells use a sophisticated communication system to coordinate responses to infection and maintain inflammation in the body.
› Verified 4 days ago
News Archive
Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows. The risk was highest in the first two months of opioid use.
Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented.
A study published in Science examines a key player in conditions such as cancer, inflammatory bowel disease, rheumatoid arthritis and asthma and has shown that cells use a sophisticated communication system to coordinate responses to infection and maintain inflammation in the body.
› Verified 4 days ago
Avalon Behavior Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1190 E Washington St, Ph29, Tampa, FL 33602 Phone: 510-313-8290 | |
Varghese Kodiyan Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 602 Shellcracker Ct, Tampa, FL 33613 Phone: 813-245-7326 | |
Tampa Life Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 13035 W. Linebaugh Ave #101 Ste G, Tampa, FL 33626 Phone: 813-906-8852 | |
Vip Senior Wellness Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 10115 Vista Pointe Dr, Tampa, FL 33635 Phone: 718-942-6595 | |
Crudup Psychological Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10001 Cross Creek Blvd, Tampa, FL 33647 Phone: 386-243-9220 | |
Grow, Empower, Transform Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13542 N Florida Ave Ste 210, Tampa, FL 33613 Phone: 813-563-8227 |